{"product_id":"mepilex-xt-15x15cm-5s-211300","title":"Molnlycke Mepilex XT 15x15 cm 5s (211300)","description":"\u003cdiv style=\"background: #f8f9fa; border-left: 4px solid #0057a8; padding: 12px 16px; margin-bottom: 20px;\" id=\"ai-summary\"\u003e\n\u003cstrong\u003eClinical Summary:\u003c\/strong\u003e Mölnlycke Mepilex XT (REF 211300) is a sterile, conformable polyurethane foam dressing with Safetac silicone adhesive technology and integrated exudate channels for absorbing low- to high-viscosity exudate. The 15 x 15 cm dressing is intended for acute and chronic exuding wounds across all healing phases, including pressure injuries, leg and foot ulcers, skin tears and secondary-healing surgical wounds. CE-marked under EU MDR 2017\/745 and supplied in cartons of 5.\u003c\/div\u003e\n\u003ch3\u003eProduct Overview\u003c\/h3\u003e\n\u003cp\u003eMepilex XT is an absorbent foam dressing engineered for moderately to highly exuding wounds where viscous exudate is present. The dressing combines a soft, conformable polyurethane foam pad with an inner channelled wound-contact layer bonded with Safetac, the original silicone adhesive technology. Channels in the contact layer transport viscous exudate into the absorbent core while preserving a moist wound environment consistent with TIME (Tissue, Infection\/inflammation, Moisture, Edges) wound-bed preparation principles.\u003c\/p\u003e\n\u003cp\u003eSafetac creates a soft seal at the periwound skin that minimises lateral spread of exudate, reducing the risk of maceration and skin stripping at dressing change. Clinical evaluations demonstrate atraumatic removal compared with conventional adhesives, supporting the WUWHS minimising-pain-at-dressing-change consensus and reducing patient-reported pain scores. The dressing is intended for use under graduated compression therapy in venous leg ulcer management when clinically indicated.\u003c\/p\u003e\n\u003ch3\u003eSpecifications\u003c\/h3\u003e\n\u003ctable style=\"border-collapse: collapse; width: 100%;\" cellpadding=\"6\" border=\"1\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eManufacturer\u003c\/th\u003e\n\u003ctd\u003eMölnlycke Health Care AB (Sweden)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eProduct \/ REF\u003c\/th\u003e\n\u003ctd\u003eMepilex XT, REF 211300\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eDressing Size\u003c\/th\u003e\n\u003ctd\u003e15 cm x 15 cm\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003ePack Size\u003c\/th\u003e\n\u003ctd\u003e5 dressings per carton\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eConstruction\u003c\/th\u003e\n\u003ctd\u003ePolyurethane absorbent foam pad with channelled Safetac silicone wound-contact layer and vapour-permeable polyurethane backing film\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eAdhesive\u003c\/th\u003e\n\u003ctd\u003eSafetac soft silicone (atraumatic, repositionable)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eExudate Handling\u003c\/th\u003e\n\u003ctd\u003eAbsorbs low- to high-viscosity exudate; vertical wicking; reduced lateral spread\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eSterility\u003c\/th\u003e\n\u003ctd\u003eSterile (ethylene oxide); single-use\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eLatex Content\u003c\/th\u003e\n\u003ctd\u003eNot made with natural rubber latex\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eShelf Life\u003c\/th\u003e\n\u003ctd\u003eRefer to outer carton; store below 35°C, dry\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eRegulatory\u003c\/th\u003e\n\u003ctd\u003eCE-marked under EU MDR 2017\/745; FDA 510(k) cleared (Class II, A6210); ISO 13485 quality system\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eHCPCS\u003c\/th\u003e\n\u003ctd\u003eA6210 (foam dressing, with adhesive border, \u0026gt;48 sq in)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch3\u003eClinical Indications\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003ePressure injuries (Stage II and beyond) with moderate to heavy exudate\u003c\/li\u003e\n\u003cli\u003eVenous leg ulcers and arterial leg ulcers under appropriate compression or off-loading\u003c\/li\u003e\n\u003cli\u003eDiabetic foot ulcers requiring conformable foam under contact-cast or off-loading\u003c\/li\u003e\n\u003cli\u003eTraumatic wounds including skin tears (ISTAP Type 1, 2 and 3)\u003c\/li\u003e\n\u003cli\u003eSecondary-healing post-surgical wounds and dehisced incisions\u003c\/li\u003e\n\u003cli\u003eModerately exuding partial-thickness burns under physician supervision\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eFrequently Asked Questions\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eWhy are exudate channels useful for viscous exudate?\u003c\/strong\u003e\u003cbr\u003eStandard foam dressings rely on capillary uptake, which can stall when exudate is highly viscous (for example chronic venous ulcer or sloughy wound exudate). The channelled Safetac contact layer of Mepilex XT provides preferential pathways into the foam core, supporting the moisture-balance objective described in the WUWHS Wound Exudate principles document.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow is the 15 x 15 cm size selected versus 10 x 10 cm?\u003c\/strong\u003e\u003cbr\u003eEWMA practice recommends a dressing margin of at least 1–2 cm beyond the wound edge onto intact periwound skin. The 15 x 15 cm presentation is suited to wounds of approximately 11 x 11 cm or smaller; for larger wounds use multiple dressings or a larger format.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCan the dressing be left in place under compression therapy?\u003c\/strong\u003e\u003cbr\u003eYes, Mepilex XT is designed for use under multilayer compression bandaging. Wear time is determined by clinical assessment of exudate strikethrough, periwound skin condition and infection signs, typically up to 7 days when not saturated.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eHow is the dressing supplied for Singapore healthcare buyers?\u003c\/strong\u003e\u003cbr\u003eEMIS supplies Mepilex XT 211300 in original Mölnlycke cartons (5 dressings per carton). Product is intended for healthcare-professional use; bulk and institutional pricing for clinics, nursing homes and community-care providers in Singapore is available on request, with HSA-compliant import documentation.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs Mepilex XT compatible with topical antimicrobials?\u003c\/strong\u003e\u003cbr\u003eMepilex XT is non-medicated; it is compatible with most topical antiseptics and antimicrobials commonly used in wound bed preparation. Where infection is confirmed or suspected, consider an antimicrobial primary layer (for example Mepilex Ag) consistent with IWII Wound Infection in Clinical Practice 2022 guidance.\u003c\/p\u003e","brand":"Molnlycke","offers":[{"title":"Default Title","offer_id":42751420891214,"sku":"23062222","price":92.61,"currency_code":"SGD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0613\/3763\/2846\/files\/45_cc03d4eb-f1ea-4c67-b43b-68b802c17250.png?v=1777428233","url":"https:\/\/www.emis.asia\/zh\/products\/mepilex-xt-15x15cm-5s-211300","provider":"EMIS +","version":"1.0","type":"link"}